Search Results 51-60 of 520 for ⚕[돈버는게임:로아월드] 프리베네 린프리 프리베네 투데이프리⚕

  1. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

    Additional contact information. Non-cancer trials contact form. Phone: 800-664-4542 (toll-free). International patient clinical studies questions. Phone: 507 ...

  2. A Study to Evaluate the Safety and Effectiveness of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy - Mayo Clinic

    Additional contact information. Non-cancer trials contact form. Phone: 800-664-4542 (toll-free). International patient clinical studies questions. Phone: 507 ...

  3. A Study to Evaluate Abemaciclib to Treat Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration - Mayo Clinic

    The purpose of this study is to evaluate the 12-week progression free survival (PFS) rate in treated subjects, based on historical sarcoma trial outcomes ...

  4. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

    Phone: 855-776-0015 (toll-free). International patient clinical studies questions. Phone: 507-284-8884; Email: intl.mcr@mayo.edu. More about research at Mayo ...

  5. Alternative medicine

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  6. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

    Phone: 855-776-0015 (toll-free). International patient clinical studies questions. Phone: 507-284-8884; Email: intl.mcr@mayo.edu. More about research at Mayo ...

  7. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    JCAR017 is a CAR-T therapy directed against CD19 (a cell surface protein on NHL cancer cells), meaning that a patient's own T-cells are collected from their ...

  8. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma - Mayo Clinic

    ... free survival (EFS) outcome compared with selumetinib alone for children with progressive or recurrent LGGs. Participation eligibility. Participant ...

  9. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely ...

  10. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety, disease response, and drug /body interactions of rSIFN-co at different dose levels to demonstrate optimal ...